Strategic Diagnostics Inc. Announces Progress in Advancing Clinical Biomarker Discovery
NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) – today announced progress in collaborating with the Kleberg Center for Molecular Markers at The University of Texas M. D. Anderson Cancer Center. The center is currently testing SDI’s Genomic Antibody Technology™ (GAT) platform in oncology biomarker discovery research.